Targeting Ceramide Signaling: Enhancing Healthy Aging and Combating Tauopathy in Mammals
- Institution
- University of Alabama at Birmingham, AL
- Principal investigator
- Liou Sun
- Funding
- $754K
- Duration
- 2024–2029
Moonbase score
Still being scored
Abstract
The study investigates the association between growth hormone deficiency and longevity in mouse models. We discovered that GHRH-KO mice with extended lifespans have different circulating lipid profiles, with ceramides being the most significantly altered lipid class. Ceramides have been implicated in several pathways related to aging, including insulin resistance, mitochondrial dysfunction, inflammation, apoptosis, and cellular senescence. The study aims to determine the role of ceramides in regulating healthspan and lifespan in mice, and to investigate the impact of genetic and pharmacological interventions that lower ceramide levels. The research approach involves integrating the understanding of GH action and ceramide signaling from the cellular and tissue levels to whole-animal outcomes. The results of this proposal will provide new insights into the differential mechanisms of action and offer the possibility of developing translational interventions. The proposed project is novel and has the potential to revolutionize our understanding of mammalian aging and longevity.
Research team
- Scott A SummersPI
- Liou SunPI
LOADING MOONBASE SCORE
Questions for University of Alabama at Birmingham
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · University of UtahNot yet scored
2025 AAIP Academic Career Development Workshop
Maija Holsti · $34K · 2025–2026
- NIH · University of UtahNot yet scored
Ceramides in Diastolic Heart Failure
William L Holland · $710K · 2024–2029
- NIH · University of UtahNot yet scored
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer
Mary Christine Playdon · $876K · 2022–2027